“Evidence-based medicine” is vastly different in the T3 paradigm versus the TSH paradigm. They rely on different bodies of evidence. They interpret evidence in different ways. They aim to achieve different goals.
Our campaign champions the T3 paradigm because it is far more capable of achieving optimal thyroid hormone status for patients on lifelong therapy, while the TSH paradigm fails many patients.
The TSH paradigm does not consider T3 levels and patients’ symptoms as important evidence compared with the TSH level. In the TSH paradigm, whenever a patient’s TSH is within the laboratory reference range, all other evidence of hypothyroidism is discounted as irrelevant, and symptoms are attributed to other health conditions.
If you want to provide Canadian doctors the freedom, tools, and encouragement to care for patients within the T3 paradigm, sign our federal petition before December 25, 2018.
Full text of the infographic:
T3 Paradigm: 1) The most important, most active thyroid hormone. Required by every organ and tissue. T3 insufficiency is hypothyroidism. 2) Its primary usefulness is in optimizing thyroid hormone therapy to provide sufficient T3 in bloodstream. 3) The paradigm interprets the 3-way relationship between T3, T4, and TSH in the context of symptoms and signs to discover a patient’s optimal T3 set-point for health. 4) Any mode of thyroid therapy including T4 monotherapy, desiccated thyroid, and T3 therapy may be tools to achieve optimal T3 levels.
TSH Paradigm: 1) Pituitary TSH regulates the healthy thyroid gland and responds to T4 and T3 levels in the pituitary. TSH is associated with thyroid status. 2) Its primary usefulness is in screening and diagnosis of thyroid gland failure and T4 insufficiency — before therapy begins. 3) The paradigm relies on population-wide statistical reference ranges to determine acceptable levels of TSH, T4, and T3 in bloodstream, but prioritizes TSH above all. 4) Only T4 monotherapy is permitted. The goal is to keep TSH within the laboratory reference range, regardless of symptoms, T3 or T4.